Eisai wins latest round in Japanese Aricept patent extension case
This article was originally published in Scrip
Executive Summary
The Intellectual Property High Court of Japan has upheld a decision by the country's Patent Office to grant an extension to the local patent for Eisai's Aricept (donepezil) in relation to its use in severe Alzheimer's dementia.